Status:
COMPLETED
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Endometrial Cancer
Fallopian Tube Cancer
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer. NBI is a kind of light. Normally, white light is used during surgery. White lig...
Eligibility Criteria
Inclusion
- Patients must meet one (or more) of the following criteria:
- Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma (all stage, grade and histology)
- Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)
- Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)
- Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)
- Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)
- Gastrointestinal carcinoma (all histology, stage and grade)
- Pancreatic carcinoma (all histology, stage and grade)
- Lung cancer (all histology, stage and grade)
- Esophageal carcinoma (all histology, stage and grade)
- Suspected or pathologically confirmed metastatic disease to the lung (all disease primaries)
- Suspected or pathologically confirmed malignant pleural effusion (all disease primaries)
- Patients must meet all of the following criteria:
- Planned thorascopic robotic or laparoscopic surgical approach
- \>18 years old
- Not pregnant
- Able to give consent Participation in other research protocols does not exclude a patient from participation in this study.
Exclusion
- None
Key Trial Info
Start Date :
December 14 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 29 2018
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT01262040
Start Date
December 14 2010
End Date
October 29 2018
Last Update
November 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065